Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
Clinical trial NCT02814643 · COMPLETED
Trial details
- NCT number
- NCT02814643
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-01-24
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.